ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Risedronate Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-15T3750
Home | Market Reports | Health| Pharmacy
Global Risedronate Market Insights Forecast to 2028
BUY CHAPTERS

Global Risedronate Market Insights, Forecast to 2030

Code: QYRE-Auto-15T3750
Report
December 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Amgen Inc
TEVA
Mylan NV
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals

Risedronate Market

Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).
The global Risedronate market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Risedronate is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Risedronate include Merck, Amgen, Teva, Mylan, Apotex, Sanofi, Abbott, Novartis and Tecoland, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Risedronate, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Risedronate, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Risedronate, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Risedronate sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Risedronate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Risedronate sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Risedronate Market Report

Report Metric Details
Report Name Risedronate Market
Segment by Type
  • 5 mg Tablets
  • 35 mg Tablets
  • 75 mg Tablets
  • 150 mg Tablets
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Mylan, Apotex, Sanofi, Abbott, Novartis, Tecoland, Taj Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Risedronate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Risedronate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Risedronate sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Risedronate Market report?

Ans: The main players in the Risedronate Market are Teva, Mylan, Apotex, Sanofi, Abbott, Novartis, Tecoland, Taj Pharmaceuticals

What are the Application segmentation covered in the Risedronate Market report?

Ans: The Applications covered in the Risedronate Market report are Postmenopausal Osteoporosis, Men with Osteoporosis

What are the Type segmentation covered in the Risedronate Market report?

Ans: The Types covered in the Risedronate Market report are 5 mg Tablets, 35 mg Tablets, 75 mg Tablets, 150 mg Tablets

Recommended Reports

Bone Disease Treatment

Osteoporosis & Bisphosphonates

Bone & Joint Drug

1 Study Coverage
1.1 Risedronate Product Introduction
1.2 Market by Type
1.2.1 Global Risedronate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 5 mg Tablets
1.2.3 35 mg Tablets
1.2.4 75 mg Tablets
1.2.5 150 mg Tablets
1.3 Market by Application
1.3.1 Global Risedronate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Risedronate Sales Estimates and Forecasts 2019-2030
2.2 Global Risedronate Revenue by Region
2.2.1 Global Risedronate Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Risedronate Revenue by Region (2019-2024)
2.2.3 Global Risedronate Revenue by Region (2025-2030)
2.2.4 Global Risedronate Revenue Market Share by Region (2019-2030)
2.3 Global Risedronate Sales Estimates and Forecasts 2019-2030
2.4 Global Risedronate Sales by Region
2.4.1 Global Risedronate Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Risedronate Sales by Region (2019-2024)
2.4.3 Global Risedronate Sales by Region (2025-2030)
2.4.4 Global Risedronate Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Risedronate Sales by Manufacturers
3.1.1 Global Risedronate Sales by Manufacturers (2019-2024)
3.1.2 Global Risedronate Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Risedronate in 2023
3.2 Global Risedronate Revenue by Manufacturers
3.2.1 Global Risedronate Revenue by Manufacturers (2019-2024)
3.2.2 Global Risedronate Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Risedronate Revenue in 2023
3.3 Global Key Players of Risedronate, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Risedronate Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Risedronate, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Risedronate, Product Offered and Application
3.8 Global Key Manufacturers of Risedronate, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Risedronate Sales by Type
4.1.1 Global Risedronate Historical Sales by Type (2019-2024)
4.1.2 Global Risedronate Forecasted Sales by Type (2025-2030)
4.1.3 Global Risedronate Sales Market Share by Type (2019-2030)
4.2 Global Risedronate Revenue by Type
4.2.1 Global Risedronate Historical Revenue by Type (2019-2024)
4.2.2 Global Risedronate Forecasted Revenue by Type (2025-2030)
4.2.3 Global Risedronate Revenue Market Share by Type (2019-2030)
4.3 Global Risedronate Price by Type
4.3.1 Global Risedronate Price by Type (2019-2024)
4.3.2 Global Risedronate Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Risedronate Sales by Application
5.1.1 Global Risedronate Historical Sales by Application (2019-2024)
5.1.2 Global Risedronate Forecasted Sales by Application (2025-2030)
5.1.3 Global Risedronate Sales Market Share by Application (2019-2030)
5.2 Global Risedronate Revenue by Application
5.2.1 Global Risedronate Historical Revenue by Application (2019-2024)
5.2.2 Global Risedronate Forecasted Revenue by Application (2025-2030)
5.2.3 Global Risedronate Revenue Market Share by Application (2019-2030)
5.3 Global Risedronate Price by Application
5.3.1 Global Risedronate Price by Application (2019-2024)
5.3.2 Global Risedronate Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Risedronate Market Size by Type
6.1.1 US & Canada Risedronate Sales by Type (2019-2030)
6.1.2 US & Canada Risedronate Revenue by Type (2019-2030)
6.2 US & Canada Risedronate Market Size by Application
6.2.1 US & Canada Risedronate Sales by Application (2019-2030)
6.2.2 US & Canada Risedronate Revenue by Application (2019-2030)
6.3 US & Canada Risedronate Market Size by Country
6.3.1 US & Canada Risedronate Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Risedronate Sales by Country (2019-2030)
6.3.3 US & Canada Risedronate Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Risedronate Market Size by Type
7.1.1 Europe Risedronate Sales by Type (2019-2030)
7.1.2 Europe Risedronate Revenue by Type (2019-2030)
7.2 Europe Risedronate Market Size by Application
7.2.1 Europe Risedronate Sales by Application (2019-2030)
7.2.2 Europe Risedronate Revenue by Application (2019-2030)
7.3 Europe Risedronate Market Size by Country
7.3.1 Europe Risedronate Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Risedronate Sales by Country (2019-2030)
7.3.3 Europe Risedronate Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Risedronate Market Size
8.1.1 China Risedronate Sales (2019-2030)
8.1.2 China Risedronate Revenue (2019-2030)
8.2 China Risedronate Market Size by Application
8.2.1 China Risedronate Sales by Application (2019-2030)
8.2.2 China Risedronate Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Risedronate Market Size by Type
9.1.1 Asia Risedronate Sales by Type (2019-2030)
9.1.2 Asia Risedronate Revenue by Type (2019-2030)
9.2 Asia Risedronate Market Size by Application
9.2.1 Asia Risedronate Sales by Application (2019-2030)
9.2.2 Asia Risedronate Revenue by Application (2019-2030)
9.3 Asia Risedronate Sales by Region
9.3.1 Asia Risedronate Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Risedronate Revenue by Region (2019-2030)
9.3.3 Asia Risedronate Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Risedronate Market Size by Type
10.1.1 Middle East, Africa and Latin America Risedronate Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Risedronate Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Risedronate Market Size by Application
10.2.1 Middle East, Africa and Latin America Risedronate Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Risedronate Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Risedronate Sales by Country
10.3.1 Middle East, Africa and Latin America Risedronate Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Risedronate Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Risedronate Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Amgen
11.2.1 Amgen Company Information
11.2.2 Amgen Overview
11.2.3 Amgen Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Amgen Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Mylan Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Apotex
11.5.1 Apotex Company Information
11.5.2 Apotex Overview
11.5.3 Apotex Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Apotex Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Apotex Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sanofi Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Overview
11.7.3 Abbott Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Abbott Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Recent Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Overview
11.8.3 Novartis Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Novartis Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Tecoland
11.9.1 Tecoland Company Information
11.9.2 Tecoland Overview
11.9.3 Tecoland Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Tecoland Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tecoland Recent Developments
11.10 Taj Pharmaceuticals
11.10.1 Taj Pharmaceuticals Company Information
11.10.2 Taj Pharmaceuticals Overview
11.10.3 Taj Pharmaceuticals Risedronate Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Taj Pharmaceuticals Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Taj Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Risedronate Industry Chain Analysis
12.2 Risedronate Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Risedronate Production Mode & Process
12.4 Risedronate Sales and Marketing
12.4.1 Risedronate Sales Channels
12.4.2 Risedronate Distributors
12.5 Risedronate Customers
13 Market Dynamics
13.1 Risedronate Industry Trends
13.2 Risedronate Market Drivers
13.3 Risedronate Market Challenges
13.4 Risedronate Market Restraints
14 Key Findings in The Global Risedronate Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Merck
Amgen Inc
TEVA
Mylan NV
Apotex
Sanofi
Abbott
Novartis
Tecoland
Taj Pharmaceuticals
List of Tables
    Table 1. Global Risedronate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of 5 mg Tablets
    Table 3. Major Manufacturers of 35 mg Tablets
    Table 4. Major Manufacturers of 75 mg Tablets
    Table 5. Major Manufacturers of 150 mg Tablets
    Table 6. Global Risedronate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Risedronate Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Risedronate Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global Risedronate Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global Risedronate Revenue Market Share by Region (2019-2024)
    Table 11. Global Risedronate Revenue Market Share by Region (2025-2030)
    Table 12. Global Risedronate Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global Risedronate Sales by Region (2019-2024) & (MT)
    Table 14. Global Risedronate Sales by Region (2025-2030) & (MT)
    Table 15. Global Risedronate Sales Market Share by Region (2019-2024)
    Table 16. Global Risedronate Sales Market Share by Region (2025-2030)
    Table 17. Global Risedronate Sales by Manufacturers (2019-2024) & (MT)
    Table 18. Global Risedronate Sales Share by Manufacturers (2019-2024)
    Table 19. Global Risedronate Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global Risedronate Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of Risedronate, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. Risedronate Price by Manufacturers 2019-2024 (USD/Kg)
    Table 23. Global Risedronate Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global Risedronate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Risedronate as of 2023)
    Table 25. Global Key Manufacturers of Risedronate, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of Risedronate, Product Offered and Application
    Table 27. Global Key Manufacturers of Risedronate, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Risedronate Sales by Type (2019-2024) & (MT)
    Table 30. Global Risedronate Sales by Type (2025-2030) & (MT)
    Table 31. Global Risedronate Sales Share by Type (2019-2024)
    Table 32. Global Risedronate Sales Share by Type (2025-2030)
    Table 33. Global Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global Risedronate Revenue Share by Type (2019-2024)
    Table 36. Global Risedronate Revenue Share by Type (2025-2030)
    Table 37. Risedronate Price by Type (2019-2024) & (USD/Kg)
    Table 38. Global Risedronate Price Forecast by Type (2025-2030) & (USD/Kg)
    Table 39. Global Risedronate Sales by Application (2019-2024) & (MT)
    Table 40. Global Risedronate Sales by Application (2025-2030) & (MT)
    Table 41. Global Risedronate Sales Share by Application (2019-2024)
    Table 42. Global Risedronate Sales Share by Application (2025-2030)
    Table 43. Global Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global Risedronate Revenue Share by Application (2019-2024)
    Table 46. Global Risedronate Revenue Share by Application (2025-2030)
    Table 47. Risedronate Price by Application (2019-2024) & (USD/Kg)
    Table 48. Global Risedronate Price Forecast by Application (2025-2030) & (USD/Kg)
    Table 49. US & Canada Risedronate Sales by Type (2019-2024) & (MT)
    Table 50. US & Canada Risedronate Sales by Type (2025-2030) & (MT)
    Table 51. US & Canada Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada Risedronate Sales by Application (2019-2024) & (MT)
    Table 54. US & Canada Risedronate Sales by Application (2025-2030) & (MT)
    Table 55. US & Canada Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada Risedronate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada Risedronate Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada Risedronate Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada Risedronate Sales by Country (2019-2024) & (MT)
    Table 61. US & Canada Risedronate Sales by Country (2025-2030) & (MT)
    Table 62. Europe Risedronate Sales by Type (2019-2024) & (MT)
    Table 63. Europe Risedronate Sales by Type (2025-2030) & (MT)
    Table 64. Europe Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe Risedronate Sales by Application (2019-2024) & (MT)
    Table 67. Europe Risedronate Sales by Application (2025-2030) & (MT)
    Table 68. Europe Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe Risedronate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe Risedronate Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe Risedronate Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe Risedronate Sales by Country (2019-2024) & (MT)
    Table 74. Europe Risedronate Sales by Country (2025-2030) & (MT)
    Table 75. China Risedronate Sales by Type (2019-2024) & (MT)
    Table 76. China Risedronate Sales by Type (2025-2030) & (MT)
    Table 77. China Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China Risedronate Sales by Application (2019-2024) & (MT)
    Table 80. China Risedronate Sales by Application (2025-2030) & (MT)
    Table 81. China Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia Risedronate Sales by Type (2019-2024) & (MT)
    Table 84. Asia Risedronate Sales by Type (2025-2030) & (MT)
    Table 85. Asia Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia Risedronate Sales by Application (2019-2024) & (MT)
    Table 88. Asia Risedronate Sales by Application (2025-2030) & (MT)
    Table 89. Asia Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia Risedronate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia Risedronate Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia Risedronate Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia Risedronate Sales by Region (2019-2024) & (MT)
    Table 95. Asia Risedronate Sales by Region (2025-2030) & (MT)
    Table 96. Middle East, Africa and Latin America Risedronate Sales by Type (2019-2024) & (MT)
    Table 97. Middle East, Africa and Latin America Risedronate Sales by Type (2025-2030) & (MT)
    Table 98. Middle East, Africa and Latin America Risedronate Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Risedronate Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Risedronate Sales by Application (2019-2024) & (MT)
    Table 101. Middle East, Africa and Latin America Risedronate Sales by Application (2025-2030) & (MT)
    Table 102. Middle East, Africa and Latin America Risedronate Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Risedronate Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Risedronate Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America Risedronate Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Risedronate Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Risedronate Sales by Country (2019-2024) & (MT)
    Table 108. Middle East, Africa and Latin America Risedronate Sales by Country (2025-2030) & (MT)
    Table 109. Merck Company Information
    Table 110. Merck Description and Major Businesses
    Table 111. Merck Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 112. Merck Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. Merck Recent Developments
    Table 114. Amgen Company Information
    Table 115. Amgen Description and Major Businesses
    Table 116. Amgen Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 117. Amgen Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Amgen Recent Developments
    Table 119. Teva Company Information
    Table 120. Teva Description and Major Businesses
    Table 121. Teva Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 122. Teva Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. Teva Recent Developments
    Table 124. Mylan Company Information
    Table 125. Mylan Description and Major Businesses
    Table 126. Mylan Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 127. Mylan Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Mylan Recent Developments
    Table 129. Apotex Company Information
    Table 130. Apotex Description and Major Businesses
    Table 131. Apotex Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 132. Apotex Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Apotex Recent Developments
    Table 134. Sanofi Company Information
    Table 135. Sanofi Description and Major Businesses
    Table 136. Sanofi Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 137. Sanofi Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Sanofi Recent Developments
    Table 139. Abbott Company Information
    Table 140. Abbott Description and Major Businesses
    Table 141. Abbott Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 142. Abbott Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Abbott Recent Developments
    Table 144. Novartis Company Information
    Table 145. Novartis Description and Major Businesses
    Table 146. Novartis Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 147. Novartis Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. Novartis Recent Developments
    Table 149. Tecoland Company Information
    Table 150. Tecoland Description and Major Businesses
    Table 151. Tecoland Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 152. Tecoland Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Tecoland Recent Developments
    Table 154. Taj Pharmaceuticals Company Information
    Table 155. Taj Pharmaceuticals Description and Major Businesses
    Table 156. Taj Pharmaceuticals Risedronate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 157. Taj Pharmaceuticals Risedronate Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Taj Pharmaceuticals Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. Risedronate Distributors List
    Table 162. Risedronate Customers List
    Table 163. Risedronate Market Trends
    Table 164. Risedronate Market Drivers
    Table 165. Risedronate Market Challenges
    Table 166. Risedronate Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Risedronate Product Picture
    Figure 2. Global Risedronate Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Risedronate Market Share by Type in 2023 & 2030
    Figure 4. 5 mg Tablets Product Picture
    Figure 5. 35 mg Tablets Product Picture
    Figure 6. 75 mg Tablets Product Picture
    Figure 7. 150 mg Tablets Product Picture
    Figure 8. Global Risedronate Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Risedronate Market Share by Application in 2023 & 2030
    Figure 10. Postmenopausal Osteoporosis
    Figure 11. Men with Osteoporosis
    Figure 12. Risedronate Report Years Considered
    Figure 13. Global Risedronate Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Risedronate Revenue 2019-2030 (US$ Million)
    Figure 15. Global Risedronate Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 16. Global Risedronate Revenue Market Share by Region (2019-2030)
    Figure 17. Global Risedronate Sales 2019-2030 ((MT)
    Figure 18. Global Risedronate Sales Market Share by Region (2019-2030)
    Figure 19. US & Canada Risedronate Sales YoY (2019-2030) & (MT)
    Figure 20. US & Canada Risedronate Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. Europe Risedronate Sales YoY (2019-2030) & (MT)
    Figure 22. Europe Risedronate Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. China Risedronate Sales YoY (2019-2030) & (MT)
    Figure 24. China Risedronate Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Asia (excluding China) Risedronate Sales YoY (2019-2030) & (MT)
    Figure 26. Asia (excluding China) Risedronate Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Middle East, Africa and Latin America Risedronate Sales YoY (2019-2030) & (MT)
    Figure 28. Middle East, Africa and Latin America Risedronate Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. The Risedronate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 30. The Top 5 and 10 Largest Manufacturers of Risedronate in the World: Market Share by Risedronate Revenue in 2023
    Figure 31. Global Risedronate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 32. Global Risedronate Sales Market Share by Type (2019-2030)
    Figure 33. Global Risedronate Revenue Market Share by Type (2019-2030)
    Figure 34. Global Risedronate Sales Market Share by Application (2019-2030)
    Figure 35. Global Risedronate Revenue Market Share by Application (2019-2030)
    Figure 36. US & Canada Risedronate Sales Market Share by Type (2019-2030)
    Figure 37. US & Canada Risedronate Revenue Market Share by Type (2019-2030)
    Figure 38. US & Canada Risedronate Sales Market Share by Application (2019-2030)
    Figure 39. US & Canada Risedronate Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Risedronate Revenue Share by Country (2019-2030)
    Figure 41. US & Canada Risedronate Sales Share by Country (2019-2030)
    Figure 42. U.S. Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 43. Canada Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 44. Europe Risedronate Sales Market Share by Type (2019-2030)
    Figure 45. Europe Risedronate Revenue Market Share by Type (2019-2030)
    Figure 46. Europe Risedronate Sales Market Share by Application (2019-2030)
    Figure 47. Europe Risedronate Revenue Market Share by Application (2019-2030)
    Figure 48. Europe Risedronate Revenue Share by Country (2019-2030)
    Figure 49. Europe Risedronate Sales Share by Country (2019-2030)
    Figure 50. Germany Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 51. France Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 52. U.K. Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 53. Italy Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 54. Russia Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 55. China Risedronate Sales Market Share by Type (2019-2030)
    Figure 56. China Risedronate Revenue Market Share by Type (2019-2030)
    Figure 57. China Risedronate Sales Market Share by Application (2019-2030)
    Figure 58. China Risedronate Revenue Market Share by Application (2019-2030)
    Figure 59. Asia Risedronate Sales Market Share by Type (2019-2030)
    Figure 60. Asia Risedronate Revenue Market Share by Type (2019-2030)
    Figure 61. Asia Risedronate Sales Market Share by Application (2019-2030)
    Figure 62. Asia Risedronate Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Risedronate Revenue Share by Region (2019-2030)
    Figure 64. Asia Risedronate Sales Share by Region (2019-2030)
    Figure 65. Japan Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 66. South Korea Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 67. China Taiwan Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 68. Southeast Asia Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 69. India Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 70. Middle East, Africa and Latin America Risedronate Sales Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Risedronate Revenue Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Risedronate Sales Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Risedronate Revenue Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Risedronate Revenue Share by Country (2019-2030)
    Figure 75. Middle East, Africa and Latin America Risedronate Sales Share by Country (2019-2030)
    Figure 76. Brazil Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 77. Mexico Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 78. Turkey Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 79. Israel Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 80. GCC Countries Risedronate Revenue (2019-2030) & (US$ Million)
    Figure 81. Risedronate Value Chain
    Figure 82. Risedronate Production Process
    Figure 83. Channels of Distribution
    Figure 84. Distributors Profiles
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Risedronate Sodium Tablets Market Research Report 2024
Global Zoledronic Acid Market Insights Forecast to 2030
Global Bisphosphonates Market Insights Forecast to 2030
Global Alendronate Market Insights Forecast to 2030
Bisphosphonate Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bone Metabolism Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Bone Metabolism Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Actonel Risedronic Acid Market Insights Forecast to 2030
Global Zoledronic Acid For Injection Market Research Report 2025
Zoledronic Acid Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ibandronate Market Insights Forecast to 2030
Global Ibandronic Acid Market Research Report 2024
Global Alendronic Acid Market Research Report 2024
Global Risedronate Sodium API Market Research Report 2025
Global Phosphonate Market Research Report 2025
Global Organophosphonates Market Insights Forecast to 2030
Global Pamidronate Disodium API Market Research Report 2024
Global Postmenopausal Osteoporosis Drugs Market Research Report 2024
Global Medication Treatment of Metastatic Bone Disease Market Insights Forecast to 2030
Global Paget s Disease Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions